STADA brings in Biogen exec to head Specialty business

German generics and consumer healthcare major STADA Arzneimittel has appointed former Biogen biosimilars head Ian Henshaw to the STADA executive committee (SEC) as executive vice president (EVP) and global head of Specialty.